138 related articles for article (PubMed ID: 36605219)
1. Obeticholic acid and 5β-cholanic acid 3 exhibit anti-tumor effects on liver cancer through CXCL16/CXCR6 pathway.
Gou H; Liu S; Liu L; Luo M; Qin S; He K; Yang X
Front Immunol; 2022; 13():1095915. PubMed ID: 36605219
[TBL] [Abstract][Full Text] [Related]
2. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
[TBL] [Abstract][Full Text] [Related]
3. Precise delivery of obeticholic acid
Ji G; Ma L; Yao H; Ma S; Si X; Wang Y; Bao X; Ma L; Chen F; Ma C; Huang L; Fang X; Song W
Acta Pharm Sin B; 2020 Nov; 10(11):2171-2182. PubMed ID: 33304784
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells.
Ma C; Han M; Heinrich B; Fu Q; Zhang Q; Sandhu M; Agdashian D; Terabe M; Berzofsky JA; Fako V; Ritz T; Longerich T; Theriot CM; McCulloch JA; Roy S; Yuan W; Thovarai V; Sen SK; Ruchirawat M; Korangy F; Wang XW; Trinchieri G; Greten TF
Science; 2018 May; 360(6391):. PubMed ID: 29798856
[TBL] [Abstract][Full Text] [Related]
5. Functional role of endothelial CXCL16/CXCR6-platelet-leucocyte axis in angiotensin II-associated metabolic disorders.
Collado A; Marques P; Escudero P; Rius C; Domingo E; Martinez-Hervás S; Real JT; Ascaso JF; Piqueras L; Sanz MJ
Cardiovasc Res; 2018 Nov; 114(13):1764-1775. PubMed ID: 29800106
[TBL] [Abstract][Full Text] [Related]
6. Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells.
Germanov E; Veinotte L; Cullen R; Chamberlain E; Butcher EC; Johnston B
J Immunol; 2008 Jul; 181(1):81-91. PubMed ID: 18566372
[TBL] [Abstract][Full Text] [Related]
7. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.
Wehr A; Baeck C; Heymann F; Niemietz PM; Hammerich L; Martin C; Zimmermann HW; Pack O; Gassler N; Hittatiya K; Ludwig A; Luedde T; Trautwein C; Tacke F
J Immunol; 2013 May; 190(10):5226-36. PubMed ID: 23596313
[TBL] [Abstract][Full Text] [Related]
8. The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases.
Korbecki J; Bajdak-Rusinek K; Kupnicka P; Kapczuk P; Simińska D; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33800554
[TBL] [Abstract][Full Text] [Related]
9. CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease.
Zhu H; Zhang Q; Chen G
Int Immunopharmacol; 2019 Jul; 72():224-234. PubMed ID: 31002999
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance.
Jiang X; Shimaoka T; Kojo S; Harada M; Watarai H; Wakao H; Ohkohchi N; Yonehara S; Taniguchi M; Seino K
J Immunol; 2005 Aug; 175(4):2051-5. PubMed ID: 16081769
[TBL] [Abstract][Full Text] [Related]
11. Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma.
Yu Z; Guo J; Liu Y; Wang M; Liu Z; Gao Y; Huang L
J Nanobiotechnology; 2022 Jan; 20(1):9. PubMed ID: 34983554
[TBL] [Abstract][Full Text] [Related]
12. Role of the CXCR6/CXCL16 axis in autoimmune diseases.
Bao N; Fu B; Zhong X; Jia S; Ren Z; Wang H; Wang W; Shi H; Li J; Ge F; Chang Q; Gong Y; Liu W; Qiu F; Xu S; Li T
Int Immunopharmacol; 2023 Aug; 121():110530. PubMed ID: 37348231
[TBL] [Abstract][Full Text] [Related]
13. Discovery of small molecule antagonists of chemokine receptor CXCR6 that arrest tumor growth in SK-HEP-1 mouse xenografts as a model of hepatocellular carcinoma.
Peddibhotla S; Hershberger PM; Jason Kirby R; Sugarman E; Maloney PR; Hampton Sessions E; Divlianska D; Morfa CJ; Terry D; Pinkerton AB; Smith LH; Malany S
Bioorg Med Chem Lett; 2020 Feb; 30(4):126899. PubMed ID: 31882297
[TBL] [Abstract][Full Text] [Related]
14. Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model.
Kee JY; Ito A; Hojo S; Hashimoto I; Igarashi Y; Tsukada K; Irimura T; Shibahara N; Nakayama T; Yoshie O; Sakurai H; Saiki I; Koizumi K
Oncol Rep; 2013 Mar; 29(3):975-82. PubMed ID: 23242131
[TBL] [Abstract][Full Text] [Related]
15. The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context.
Chia TY; Billingham LK; Boland L; Katz JL; Arrieta VA; Shireman J; Rosas AL; DeLay SL; Zillinger K; Geng Y; Kruger J; Silvers C; Wang H; Vazquez Cervantes GI; Hou D; Wang S; Wan H; Sonabend A; Zhang P; Lee-Chang C; Miska J
Front Immunol; 2023; 14():1331287. PubMed ID: 38299146
[TBL] [Abstract][Full Text] [Related]
16. The Chemokine Receptor CXCR6 Evokes Reverse Signaling via the Transmembrane Chemokine CXCL16.
Adamski V; Mentlein R; Lucius R; Synowitz M; Held-Feindt J; Hattermann K
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28698473
[TBL] [Abstract][Full Text] [Related]
17. Evidence that CXCL16 is a potent mediator of angiogenesis and is involved in endothelial progenitor cell chemotaxis : studies in mice with K/BxN serum-induced arthritis.
Isozaki T; Arbab AS; Haas CS; Amin MA; Arendt MD; Koch AE; Ruth JH
Arthritis Rheum; 2013 Jul; 65(7):1736-46. PubMed ID: 23633118
[TBL] [Abstract][Full Text] [Related]
18. Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor.
Yoon MS; Pham CT; Phan MT; Shin DJ; Jang YY; Park MH; Kim SK; Kim S; Cho D
Cytotherapy; 2016 Dec; 18(12):1532-1542. PubMed ID: 27720639
[TBL] [Abstract][Full Text] [Related]
19. The role of the CXCR6/CXCL16 axis in the pathogenesis of fibrotic disease.
Wang FT; Wu TQ; Lin Y; Jiao YR; Li JY; Ruan Y; Yin L; Chen CQ
Int Immunopharmacol; 2024 May; 132():112015. PubMed ID: 38608478
[TBL] [Abstract][Full Text] [Related]
20. CXCL16/CXCR6 Axis Drives Microglia/Macrophages Phenotype in Physiological Conditions and Plays a Crucial Role in Glioma.
Lepore F; D'Alessandro G; Antonangeli F; Santoro A; Esposito V; Limatola C; Trettel F
Front Immunol; 2018; 9():2750. PubMed ID: 30542347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
